ACTRN12611000336987招募中4 期
Prospective randomised trial of intravitreal triamcinolone in the prevention of trabeculectomy failure after cataract surgery
Royal Victorian Eye and Ear0 个研究点目标入组 110 人开始时间: 2011年3月31日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 40 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Patients with a functioning glaucoma filtration bleb who are due to undergo cataract surgery with intra-ocular lens implantation.
排除标准
- •Active or recent bleb leak, known hypersensitivity to 5-FU or Triamcinolone, only eye, active or recent blebitis or endophthalmitis.Previous vitrectomy. Previous retinal detachment or tear. Inability to give informed consent. Inability to be safely administeedr an intravitreal injection.
研究者
相似试验
已完成
不适用
Randomised Controlled Trial of Intravitreal Triamcinolone in Patients with Diabetic Macular Oedema Refractory to Laser TreatmentISRCTN90614292Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
进行中（未招募）
1 期
Randomised Controlled Trial Of Intravitreal Triamcinolone In Patients With Diabetic Macular Oedema Refractory To Laser TreatmentDiabetic macular oedema affecting vision and refractory to laser treatmentEUCTR2005-000397-45-GBQueen's Medical centre40
尚未招募
不适用
To examine the visual function and thickness of macula to assess function of intravitreal injection of bevacizumab and triamcilone acetonide.CTRI/2020/11/029064Father muller medical college
进行中（未招募）
不适用
Comparison between injections into the eye ( drug Avastin) with 'pretend' injections in diabetic patients in whom no further treatment is currently available in clinic when they have developed swelling of the centre of the macular associated with lack of blood supply.Ischaemic Diabetic Macular OedemaMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012688Term: Diabetic retinal oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012661Term: Diabetic eye diseaseSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054372Term: Diabetic retinal edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10038925Term: Retinopathy diabeticSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10057915Term: Diabetic macular oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: LLTClassification code 10054109Term: Non-proliferative diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disordersEUCTR2011-003304-20-GBMoorfields Eye Hospital NHS Foundation Trust
进行中（未招募）
不适用
Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glaucoma. - Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glauRubeotic glaucoma secondary to ischaemic proliferative retinopathiesEUCTR2007-000585-21-IERoyal Victoria Eye and Ear hospital20